Stifel Maintains Hold on Insulet, Raises Price Target to $208
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Mathew Blackman has maintained a Hold rating on Insulet (NASDAQ:PODD) and increased the price target from $163 to $208. This adjustment reflects a more optimistic outlook on the company's future performance.
February 05, 2024 | 9:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Mathew Blackman has maintained a Hold rating on Insulet but raised the price target from $163 to $208, indicating a positive reassessment of the company's value.
The increase in price target from $163 to $208 by Stifel suggests a significant positive reassessment of Insulet's market position and future earnings potential. This could lead to increased investor confidence and potentially a short-term increase in stock price, despite the Hold rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100